Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 902

1.

Safety evaluation of ABELCET, an amphotericin B lipid complex (ABLC): toxicity studies in rats.

Zhang Z, Diener RM, Lipman JM.

Int J Toxicol. 2006 Jul-Aug;25(4):285-94.

PMID:
16815817
[PubMed - indexed for MEDLINE]
2.

Study of the toxicity of a new lipid complex formulation of amphotericin B.

Larabi M, Pages N, Pons F, Appel M, Gulik A, Schlatter J, Bouvet S, Barratt G.

J Antimicrob Chemother. 2004 Jan;53(1):81-8. Epub 2003 Dec 4.

PMID:
14657087
[PubMed - indexed for MEDLINE]
Free Article
3.

Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.

Sivak O, Bartlett K, Risovic V, Choo E, Marra F, Batty DS Jr, Wasan KM.

J Pharm Sci. 2004 Jun;93(6):1382-9.

PMID:
15124198
[PubMed - indexed for MEDLINE]
4.

Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model.

Cannon JP, Fiscella R, Pattharachayakul S, Garey KW, De Alba F, Piscitelli S, Edward DP, Danziger LH.

Invest Ophthalmol Vis Sci. 2003 May;44(5):2112-7.

PMID:
12714650
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats.

Bhamra R, Sa'ad A, Bolcsak LE, Janoff AS, Swenson CE.

Antimicrob Agents Chemother. 1997 May;41(5):886-92.

PMID:
9145839
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
[PubMed - indexed for MEDLINE]
8.

Comparative immunotoxicity evaluation of amphotericin B and ABELCET, an amphotericin B lipid complex (ABLC).

Zhang Z, Lipman JM, Diener RM, Thomas P.

Int J Toxicol. 2006 Nov-Dec;25(6):487-92.

PMID:
17132607
[PubMed - indexed for MEDLINE]
9.

Amphotericin B lipid complex.

Rapp RP, Gubbins PO, Evans ME.

Ann Pharmacother. 1997 Oct;31(10):1174-86. Review.

PMID:
9337444
[PubMed - indexed for MEDLINE]
10.

NTP technical report on the toxicity studies of 2- and 4-Methylimidazole (CAS No. 693-98-1 and 822-36-6) administered in feed to F344/N rats and B6C3F1 mice.

Chan PC; National Toxicology Program, US Department of Health and Human Services, Public Health Service, National Institutes of Health.

Toxic Rep Ser. 2004 Apr;(67):1-G12.

PMID:
15146214
[PubMed - indexed for MEDLINE]
11.

The reproductive and developmental toxicity of the antifungal drug Nyotran (liposomal nystatin) in rats and rabbits.

Larson JL, Wallace TL, Tyl RW, Marr MC, Myers CB, Cossum PA.

Toxicol Sci. 2000 Feb;53(2):421-9.

PMID:
10696790
[PubMed - indexed for MEDLINE]
Free Article
12.

Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.

Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.

Eur J Haematol. 2004 May;72(5):342-7.

PMID:
15059069
[PubMed - indexed for MEDLINE]
13.

Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature.

Martino R.

Curr Med Res Opin. 2004 Apr;20(4):485-504. Review.

PMID:
15119986
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.

Linden P, Williams P, Chan KM.

Clin Transplant. 2000 Aug;14(4 Pt 1):329-39.

PMID:
10945204
[PubMed - indexed for MEDLINE]
15.

Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis.

Clemons KV, Stevens DA.

J Antimicrob Chemother. 1992 Sep;30(3):353-63.

PMID:
1452501
[PubMed - indexed for MEDLINE]
17.

Tissue distribution of amphotericin B lipid complex in laboratory animals.

Olsen SJ, Swerdel MR, Blue B, Clark JM, Bonner DP.

J Pharm Pharmacol. 1991 Dec;43(12):831-5.

PMID:
1687580
[PubMed - indexed for MEDLINE]
18.

Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.

Lincopan N, Mamizuka EM, Carmona-Ribeiro AM.

J Antimicrob Chemother. 2005 May;55(5):727-34. Epub 2005 Mar 10.

PMID:
15761070
[PubMed - indexed for MEDLINE]
Free Article
19.

Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.

Cicogna CE, White MH, Bernard EM, Ishimura T, Sun M, Tong WP, Armstrong D.

Antimicrob Agents Chemother. 1997 Feb;41(2):259-61.

PMID:
9021176
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Subchronic toxicity studies of N-D-ornithyl amphotericin B methyl ester in dogs and rats.

Massa T, Sinha DP, Frantz JD, Filipek ME, Weglein RC, Steinberg SA, McGrath JT, Murphy BF, Szot RJ, Black HE, et al.

Fundam Appl Toxicol. 1985 Aug;5(4):737-53.

PMID:
4043596
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk